Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007357. doi: 10.1002/14651858.CD007357.pub2
Methods RCT, DB, single dose, 4 parallel groups
Medication administered when baseline pain reached a moderate to severe intensity
Pain assessed at 30, 60 mins, then hourly to 8 h
Participants Elective gynaecological surgery
Age range 18 to 34 years
N = 159
All F
Interventions Etodolac 25 mg, n = 40
Etodolac 100 mg, n = 40
Aspirin 650 mg, n = 39
Placebo, n = 40
Outcomes PI: non standard scale (5 point)
PR: 5 point scale - non standard wording, reverse order
PGE: non standard scale (4 point)
Adverse events: any, serious
Withdrawals
Notes Oxford Quality Score: R1, DB1, W1
Rescue medication permitted - no further details